Management of MRSA, VRE
Publisher
Springer Singapore
Reference70 articles.
1. Acar J, Casewell M, Freeman J, Friis C, Goossens H. Avoparcin and virginiamycin as animal growth promoters: a plea for science in decision-making. Clin Microbiol Infect. 2000;6(9):477–82.
2. Andreatos N, Shehadeh F, Pliakos EE, Mylonakis E. The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: a county-level, US-wide analysis. Int J Antimicrob Agents. 2018 Aug;52(2):195–200.
3. Archer GL, Niemeyer DM, Thanassi JA, Pucci MJ. Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrob Agents Chemother. 1994;38:447.
4. Asensio A, Guerrero A, Quereda C, et al. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol. 1996;17:20.
5. Atmaca O, Zarakolu P, Karahan C, Cakir B, Unal S. Risk factors and antibiotic use in methicillin-resistant Staphylococcus aureus bacteremia in hospitalized patients at Hacettepe University adult and oncology hospitals (2004-2011) and antimicrobial susceptibilities of the isolates: a nested case-control study. Mikrobiyol Bul. 2014;48(4):523–37.